Jeff Yass’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$430K Buy
12,800
+7,000
+121% +$302K ﹤0.01% 10138
2026
Q2
$242K Sell
5,800
-4,700
-45% -$173K ﹤0.01% 11544
2026
Q1
$329K Buy
+10,500
New +$295K ﹤0.01% 10674
2025
Q4
– Sell
-36,000
Closed -$1.07M – 13875
2025
Q3
$1.07M Buy
+36,000
New +$642K ﹤0.01% 7205

Other funds holding RAPP

Jeff Yass's RAPP Position: Q3 2026 in Review

Jeff Yass increased its Rapport Therapeutics (RAPP) stake by 91% in Q3 2026, buying an estimated $323K and bringing the position to 15,746 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #9611.

Jeff Yass first reported a position in RAPP in Q1 2025 and has held it in 7 quarters since. The position peaked at $628K in Q3 2025. 167 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • Jeff Yass held 15,746 shares of Rapport Therapeutics worth $529K as of Q3 2026.
  • Jeff Yass bought 7,491 Rapport Therapeutics shares in Q3 2026, an estimated $323K.
  • Rapport Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9611 holding.
  • Jeff Yass first reported a position in Rapport Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • Jeff Yass's Rapport Therapeutics position peaked at $628K in Q3 2025.
  • 167 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.